rs147050939

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 2P and 8B. PP3_ModerateBS1BS2

The NM_000751.3(CHRND):​c.1066C>T​(p.Pro356Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000596 in 1,612,914 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P356L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00062 ( 2 hom. )

Consequence

CHRND
NM_000751.3 missense

Scores

14
4

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 7.84

Publications

7 publications found
Variant links:
Genes affected
CHRND (HGNC:1965): (cholinergic receptor nicotinic delta subunit) The acetylcholine receptor of muscle has 5 subunits of 4 different types: 2 alpha and 1 each of beta, gamma and delta subunits. After acetylcholine binding, the receptor undergoes an extensive conformation change that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. Defects in this gene are a cause of multiple pterygium syndrome lethal type (MUPSL), congenital myasthenic syndrome slow-channel type (SCCMS), and congenital myasthenic syndrome fast-channel type (FCCMS). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2015]
CHRND Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 3A
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • congenital myasthenic syndrome 3B
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital myasthenic syndrome 3C
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • lethal multiple pterygium syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.912
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000622 (908/1460570) while in subpopulation NFE AF = 0.000751 (835/1111874). AF 95% confidence interval is 0.000708. There are 2 homozygotes in GnomAdExome4. There are 436 alleles in the male GnomAdExome4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000751.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRND
NM_000751.3
MANE Select
c.1066C>Tp.Pro356Ser
missense
Exon 10 of 12NP_000742.1Q07001-1
CHRND
NM_001256657.2
c.1021C>Tp.Pro341Ser
missense
Exon 9 of 11NP_001243586.1Q07001-2
CHRND
NM_001311196.2
c.763C>Tp.Pro255Ser
missense
Exon 10 of 12NP_001298125.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRND
ENST00000258385.8
TSL:1 MANE Select
c.1066C>Tp.Pro356Ser
missense
Exon 10 of 12ENSP00000258385.3Q07001-1
CHRND
ENST00000543200.5
TSL:2
c.1021C>Tp.Pro341Ser
missense
Exon 9 of 11ENSP00000438380.1Q07001-2
CHRND
ENST00000955151.1
c.865C>Tp.Pro289Ser
missense
Exon 9 of 11ENSP00000625210.1

Frequencies

GnomAD3 genomes
AF:
0.000355
AC:
54
AN:
152226
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000965
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000436
AC:
109
AN:
250238
AF XY:
0.000406
show subpopulations
Gnomad AFR exome
AF:
0.000188
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.000823
Gnomad OTH exome
AF:
0.000491
GnomAD4 exome
AF:
0.000622
AC:
908
AN:
1460570
Hom.:
2
Cov.:
32
AF XY:
0.000600
AC XY:
436
AN XY:
726632
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33452
American (AMR)
AF:
0.000179
AC:
8
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86224
European-Finnish (FIN)
AF:
0.000283
AC:
15
AN:
53060
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5112
European-Non Finnish (NFE)
AF:
0.000751
AC:
835
AN:
1111874
Other (OTH)
AF:
0.000746
AC:
45
AN:
60294
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
54
108
162
216
270
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000354
AC:
54
AN:
152344
Hom.:
0
Cov.:
33
AF XY:
0.000282
AC XY:
21
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0000962
AC:
4
AN:
41586
American (AMR)
AF:
0.000523
AC:
8
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000588
AC:
40
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000529
Hom.:
1
Bravo
AF:
0.000472
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000502
AC:
61
EpiCase
AF:
0.000654
EpiControl
AF:
0.000711

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
4
-
not provided (4)
-
1
-
Inborn genetic diseases (1)
-
1
-
Lethal multiple pterygium syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.70
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Pathogenic
0.33
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.76
D
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Uncertain
0.21
D
MetaRNN
Pathogenic
0.91
D
MetaSVM
Pathogenic
0.87
D
MutationAssessor
Pathogenic
3.6
H
PhyloP100
7.8
PrimateAI
Uncertain
0.51
T
PROVEAN
Pathogenic
-7.8
D
REVEL
Pathogenic
0.80
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.84
MVP
1.0
MPC
0.89
ClinPred
0.89
D
GERP RS
5.7
Varity_R
0.94
gMVP
0.80
Mutation Taster
=21/79
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147050939; hg19: chr2-233398659; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.